IL10RA and colon carcinoma: Mice treated with CpG plus anti-IL-10Rα have dramatically reduced C26 colon carcinoma growth, while anti-IL-10R or CpG alone does not, indicating blockade IL-10 signaling pathway together with TLR-9 stimulation promotes tumor rejection (167).